Scarica l'app Stockscreener
0.8654
2.22%
0.0188
Dopo l'orario di chiusura:
.90
0.0346
+4.00%
Precedente Chiudi:
$0.8466
Aprire:
$0.8421
Volume 24 ore:
70,414
Relative Volume:
0.44
Capitalizzazione di mercato:
$13.77M
Reddito:
$345.00K
Utile/perdita netta:
$-11.25M
Rapporto P/E:
-1.1991
EPS:
-0.7217
Flusso di cassa netto:
$-16.70M
1 W Prestazione:
-3.31%
1M Prestazione:
-16.79%
6M Prestazione:
-38.19%
1 anno Prestazione:
-37.74%
Intervallo 1D:
$0.84
$0.8963
Intervallo di 1 settimana:
$0.821
$0.9149
Portata 52W:
$0.7687
$1.8395
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Nome
Allarity Therapeutics Inc
Settore
Industria
Telefono
401-426-4664
Indirizzo
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR vs VRTX, REGN, MRNA, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.8654 | 13.77M | 345.00K | -11.25M | -16.70M | -0.7217 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-28 | Iniziato | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie
ALLR 10-Q & SEC FilingsYahoo Finance - Yahoo! Finance Canada
Form 4 Allarity Therapeutics Inc For: 9 October By Investing.com - Investing.com Nigeria
Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Allarity Therapeutics (ALLR) withholds 14,613 shares for taxes as Graff's stock grant vests. - Stock Titan
Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research - GlobeNewswire Inc.
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Benzinga
Allarity Therapeutics files for $100 million SPAC offering By Investing.com - Investing.com Australia
Allarity Therapeutics files for $100 million SPAC offering By Investing.com - Investing.com South Africa
Allarity Therapeutics files for $100 million SPAC offering - Investing.com
Allarity Therapeutics files for $100 million SPAC offering By Investing.com - Investing.com India
A former Novo Nordisk president will chair Allarity’s new acquisition company. The proposed offering is $100 million. - Stock Titan
Allarity Therapeutics Stock Price Forecast. Should You Buy ALLR? - StockInvest.us
Allarity Therapeutics Inc (ALLR) Key Financial Ratios – Valuation, Profitability & More - Value Research
Allarity Therapeutics Inc (ALLR) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Allarity Therapeutics Inc (ALLR) Peer Comparison – Compare with Others - Value Research
Allarity Therapeutics Inc (ALLR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Allarity (ALLR) Financial Update: EPS Clears the Reported Estimate in the Latest Session; Trading Response: The Stock Closes Near Unchanged at the CloseEBITDA Estimate Trend - vinanet.vn
Allarity (ALLR) Earnings Update: The Available Earnings Metric Delivers a Beat; Price Move: Shares Move 5.93% Higher for the Current SessionEarnings Seasonality - vinanet.vn
Allarity Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Allarity Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Allarity Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign - Investing News Network
Allarity Therapeutics Q2 EPS of $(0.21) beats $(0.25) estimate - scanx.trade
Allarity Therapeutics reports Q2 results, cash position - Investing.com
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign - The Manila Times
Allarity Therapeutics, Inc. 2026: Revenue $0 Net income ($3.41M), EPS ($0.21) — 10-Q Summary - TradingView
Allarity Therapeutics reports Q2 results, cash position By Investing.com - Investing.com Canada
Allarity Therapeutics (ALLR) adds $20M debt, holds $26.9M cash in Q2 2026 - Stock Titan
Allarity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready ... - Caledonian Record
Patent Gives Allarity’s Cancer-Drug Pairing Exclusivity Into 2042 - Stock Titan
Allarity Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Allarity Therapeutics Reports Second Quarter 2026 Results - GlobeNewswire
Allarity Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
ALLR Q1 2026 Earnings: Narrower-than-Expected Loss of -$0.17 Highlights Cost DisciplineEarnings Power Value - vinanet.vn
Allarity Therapeutics (ALLR) Edges Higher: Biotech Stock Tests Key $1.42 Resistance After +1.5% MoveVolume Oscillator - dars.gov.et
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - TMX Newsfile
CNSY Stock Price and Chart — NASDAQ:CNSY - tradingview.com
Allarity Therapeutics (ALLR) Gains 2.48% as Stock Holds Above Key Support ZoneDividend ETF - dars.gov.et
Allarity Therapeutics (ALLR) Gains 2.48% as Stock Holds Above Key Support ZoneVOLD Alert - vinanet.vn
Allarity Therapeutics Inc (ALLR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Allarity Therapeutics (ALLR) Slips 1.65% as Stock Tests Key Support LevelsMoving Average Ribbon - vinanet.vn
Allarity Therapeutics, Inc. Revenue Breakdown – NASDAQ:ALLR - TradingView
Allarity Therapeutics Inc (ALLR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allarity Therapeutics Inc (ALLR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Allarity Therapeutics Inc (ALLR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Allarity Therapeutics Inc (ALLR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ALLR|Allarity Therapeutics Inc|Price:1.190| - TradingKey
TradingKey - TradingKey
Allarity Therapeutics Inc Azioni (ALLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.09%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):